1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA IGF2BP2 CTRPv2 pan-cancer AAC -0.22 4e-09
mRNA LTBR CTRPv2 pan-cancer AAC -0.2 3e-06
mRNA ASAP2 CTRPv2 pan-cancer AAC -0.19 3e-06
mRNA PIK3CB CTRPv2 pan-cancer AAC -0.19 1e-08
mRNA SUMO3 CTRPv2 pan-cancer AAC -0.18 1e-07
mRNA PXN CTRPv2 pan-cancer AAC -0.17 6e-06
mRNA ARRB1 CTRPv2 pan-cancer AAC -0.17 4e-07
mRNA ARHGEF6 CTRPv2 pan-cancer AAC -0.16 3e-05
mRNA MCU CTRPv2 pan-cancer AAC -0.16 4e-06
mRNA WWC1 CTRPv2 pan-cancer AAC -0.16 9e-05
Download CSV